Danice K. Torman

Therapeutic approaches and outcomes in patients with larynx or hypopharynx high‐grade neuroendocrine carcinoma: A single‐center retrospective analysis

D. Rosenthal, R. Ferrarotto, B. Glisson, 2021, Head & neck.

Impact of Neoadjuvant Durvalumab with or without Tremelimumab on CD8 þ Tumor Lymphocyte Density, Safety, and Ef fi cacy in Patients with Oropharynx Cancer: CIAO Trial Results

C. Warneke, J. Phan, Y. Elamin, 2020 .

Response rates and survival to systemic therapy after immune checkpoint inhibitor failure in recurrent/metastatic head and neck squamous cell carcinoma.

Jason M. Johnson, J. Lee, J. Phan, 2019, Oral oncology.